MarketCap
Facebook
X
Telegram
Second Sight Medical Products Operating Cycle | EYES
Annual Operating Cycle Second Sight Medical Products
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | 224 | 269 | 277 | 149 | 627 | 663 | - | - | - |
Annual performance
Select metrics to display
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 663 | 149 | 368 |
Quarterly Operating Cycle Second Sight Medical Products
| 2026-Q2 | 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 3.08 K | 4.95 K | - | - | - | - | 1.15 K | 83.5 | 1.44 K | 41.6 K | 911 | 26 | 2.08 K | 2.06 K | 7.06 K | 53.7 | 5.31 K | 5.98 K | 13.7 K | - | 2.5 K | 8.33 K | 598 K | - | 138 K | 68.8 K | 221 K | - | 1.36 K | 631 | 2.12 K | - | - | - | - | - | - | - | - | - | - | - | - |
Quarterly performance
Select metrics to display
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 598 K | 26 | 47.1 K |
Operating Cycle of other stocks in the Medical devices industry
| Issuer | Operating Cycle | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
FONAR Corporation
FONR
|
16.3 | - | - | $ 140 M |  USA |
 |
GBS
GBS
|
151 | - | -0.57 % | $ 7.12 M | USA |
 |
NanoVibronix
NAOV
|
372 | - | - | $ 1.08 M | USA |
 |
Ra Medical Systems
RMED
|
395 | - | 10.0 % | $ 610 K | USA |
 |
ReWalk Robotics Ltd.
RWLK
|
268 | - | 7.07 % | $ 66.1 M |  Israel |
 |
STRATA Skin Sciences
SSKN
|
128 | - | - | $ 6.6 M | USA |
 |
Align Technology
ALGN
|
161 | $ 164.4 | 3.16 % | $ 11.9 B | USA |
 |
Abbott Laboratories
ABT
|
181 | $ 110.03 | -3.18 % | $ 192 B | USA |
 |
Bio-Rad Laboratories
BIO
|
285 | $ 382.08 | 3.5 % | $ 10.4 B | USA |
 |
EDAP TMS S.A.
EDAP
|
267 | - | - | $ 162 M |  France |
 |
Edwards Lifesciences Corporation
EW
|
341 | $ 102.08 | 1.29 % | $ 59.7 B | USA |
 |
Alphatec Holdings
ATEC
|
314 | $ 7.44 | -4.62 % | $ 1.12 B | USA |
 |
Avinger
AVGR
|
381 | - | -20.74 % | $ 369 K | USA |
 |
Medtronic PLC
MDT
|
230 | $ 101.83 | -2.9 % | $ 131 B | USA |
 |
ThermoGenesis Holdings
THMO
|
170 | - | -25.84 % | $ 171 K | USA |
 |
MiMedx Group
MDXG
|
180 | $ 3.31 | 0.91 % | $ 489 M | USA |
 |
Talis Biomedical Corporation
TLIS
|
30.6 | - | 3.55 % | $ 7.96 M | USA |
 |
Cognyte Software Ltd.
CGNT
|
164 | $ 8.1 | 0.06 % | $ 591 M | Israel |
 |
Myomo
MYO
|
117 | $ 1.21 | 1.68 % | $ 50.6 M | USA |
 |
CONMED Corporation
CNMD
|
270 | $ 51.44 | -2.42 % | $ 1.6 B | USA |
 |
Nano-X Imaging Ltd.
NNOX
|
39 | $ 0.24 | -3.95 % | $ 15.5 M | Israel |
 |
Penumbra
PEN
|
378 | $ 319.32 | -0.59 % | $ 12.4 B | USA |
 |
Viveve Medical
VIVE
|
186 | - | -15.35 % | $ 1.71 M | USA |
 |
Insulet Corporation
PODD
|
210 | $ 146.61 | -6.09 % | $ 10.3 B | USA |
 |
Smith & Nephew plc
SNN
|
357 | $ 31.16 | -2.72 % | $ 27 B |  Britain |
 |
Stryker Corporation
SYK
|
408 | $ 325.34 | -2.9 % | $ 124 B | USA |
 |
Tactile Systems Technology
TCMD
|
124 | $ 26.03 | -0.83 % | $ 595 M | USA |
 |
TELA Bio
TELA
|
216 | $ 0.82 | 5.24 % | $ 38.5 M | USA |
 |
TransMedics Group
TMDX
|
127 | $ 87.58 | 26.96 % | $ 2.98 B | USA |
 |
SmileDirectClub
SDC
|
236 | - | -53.45 % | $ 9.71 M | USA |
 |
Tandem Diabetes Care
TNDM
|
284 | $ 16.63 | -7.59 % | $ 1.13 B | USA |
 |
Acutus Medical
AFIB
|
232 | - | -26.83 % | $ 2.62 M | USA |
 |
BIOLASE
BIOL
|
196 | - | -13.19 % | $ 166 K | USA |
 |
Viemed Healthcare
VMD
|
49 | $ 9.14 | 1.39 % | $ 356 M | USA |
 |
SeaSpine Holdings Corporation
SPNE
|
359 | - | 0.28 % | $ 270 M | USA |
 |
Varex Imaging Corporation
VREX
|
254 | $ 18.45 | 0.03 % | $ 764 M | USA |
 |
Vivos Therapeutics
VVOS
|
21 | $ 0.09 | -8.67 % | $ 925 K | USA |
 |
Apollo Endosurgery
APEN
|
220 | - | - | $ 475 M | USA |
 |
Beyond Air
XAIR
|
137 | $ 2.15 | -1.38 % | $ 17.8 B | USA |
 |
NuVasive
NUVA
|
425 | - | - | $ 2.07 B | USA |
 |
Xtant Medical Holdings
XTNT
|
306 | $ 0.28 | -5.0 % | $ 39.1 M | USA |
 |
Zimmer Biomet Holdings
ZBH
|
402 | $ 105.43 | -1.42 % | $ 20.9 B | USA |
 |
Conformis
CFMS
|
216 | - | - | $ 16.4 M | USA |
 |
ViewRay
VRAY
|
233 | - | 1.54 % | $ 468 M | USA |
 |
Medigus Ltd.
MDGS
|
411 | - | 10.28 % | $ 55.5 M | Israel |
 |
Cutera
CUTR
|
462 | - | -10.19 % | $ 1.99 M | USA |
 |
Neovasc
NVCN
|
130 | - | - | $ 111 M |  Canada |
 |
Vapotherm
VAPO
|
305 | - | 6.72 % | $ 34 M | USA |
 |
Nevro Corp.
NVRO
|
359 | - | - | $ 217 M | USA |